The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.

Publikation

The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.

Wissenschaftlicher Artikel/Review - 18.10.2022

Mocroft Amanda, Geressu Adam, Béguelin Charles, Llibre Josep M, Lazarus Jeffrey V, Tomazic Janez, Smidt Jelena, Parczewski Milosz, Brännström Johanna, Sedlacek Dalibor, Degen Olaf, van der Valk Marc, Paduta Dzmitry, Flamholc Leo, Schmid Patrick, Orkin Chloe, Nielsen Lars N, Hoffmann Christian, Beniowski Marek, Oprea Cristiana, Begovac Josip, Peters Lars

Zitation

Mocroft A, Geressu A, Béguelin C, Llibre J, Lazarus J, Tomazic J, Smidt J, Parczewski M, Brännström J, Sedlacek D, Degen O, van der Valk M, Paduta D, Flamholc L, Schmid P, Orkin C, Nielsen L, Hoffmann C, Beniowski M, Oprea C, Begovac J, Peters L. The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe. AIDS 2022; 37:91-103.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

AIDS 2022; 37

Veröffentlichungsdatum

18.10.2022

eISSN (Online)

1473-5571

Seiten

91-103

Kurzbeschreibung/Zielsetzung

There are limited data on end-stage liver disease (ESLD) and mortality in people with HIV (PWH) coinfected with both hepatitis B virus (HBV) and hepatitis C virus (HCV).